Bioindustria Laboratorio Italiano Medicinali is an API manufacturer based in Italy. It holds 4 active US drug master files and 2 valid CEPs across a filed portfolio of 5 molecules. Its filings concentrate with AIFA (IT), ANPP (DZ) and UZPHARM (UZ). Its most recent recorded inspection, by US FDA, closed on 24 February 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Novi Ligure, United Arab Emirates | Not on file |
| FRESONARA, Italy | Not on file |
| Novi Ligure, Italy | Not on file |
| Italy, Italy | 3002717526 |
| Italy, Italy | 3002806499 |
| Molecule | Regulators | Docs |
|---|---|---|
| Prazosin | EDQM, US FDA | 2 |
| Hyaluronidase | EDQM | 1 |
| Indapamide | US FDA | 1 |
| Terazosin | US FDA | 1 |
| Torasemide | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 291 | None |
| ANPP (DZ) | 4 | None |
| UZPHARM (UZ) | 4 | None |
| NPRA (MY) | 3 | None |
| EDE (AE) | 3 | None |
| NCELS (KZ) | 1 | None |
Choose your molecules and target markets. Bioindustria Laboratorio Italiano Medicinali comes back tiered against every other supplier able to file there.
Start for free